MDLA Targets Pet Care Market Projected to Reach US$1.83 Billion
The growing trend of pet ownership in Indonesia is driving the expansion of the national pet care industry. Amid projections of an increasingly large market, PT Medela Potentia Tbk (MDLA) is broadening its business through strengthened distribution in the animal food segment.
Citing a Mordor Intelligence report, the value of Indonesia’s pet care industry is estimated to reach US$1.83 billion by 2031. Recognising this potential, MDLA through its subsidiary PT Anugrah Argon Medica (AAM) has entered into a strategic partnership with PT Compawnion Jadi Berkat (Compawnion).
The cooperation agreement was signed on 6 February 2026 by AAM President Director Juliwaty and Compawnion President Director Stephani Herman.
Through this collaboration, AAM will distribute science-based pet food products Pawmeals Dog Food and Catto Cat Food to pet shop networks and modern retail outlets across various regions of Indonesia in a phased manner.
AAM President Director Juliwaty said the partnership represents a strategic step to broaden market penetration whilst driving business growth for both parties.
“We are grateful for Compawnion’s trust in AAM as a distribution partner. We truly see that the shared vision and collaboration to deliver ideal pet products is a step towards expanding market penetration and driving mutual growth,” she said.
Meanwhile, Compawnion President Director Stephani Herman said the selection of AAM as a distribution partner was based on its reputation and robust distribution network.
“Based on field research we conducted in various cities, AAM is known for having a strong reputation and consistent service standards. Therefore, we are confident that AAM is the right distribution partner to support our expansion,” she said.
MDLA President Director Krestijanto Pandji assessed that this partnership also presents an opportunity for local products to compete in a market still dominated by imported goods.
“The pet food industry in Indonesia is mostly still controlled by foreign products. With Compawnion as a local company offering quality and diverse product innovations, this represents an opportunity for a breakthrough,” Krestijanto said.
Compawnion is a science-based pet nutrition company that has secured funding from East Ventures. The company focuses on developing products with high-integrity raw materials and measurable commercial strategies.
Meanwhile, MDLA is a healthcare business group that has been operating for more than 45 years and maintains a national distribution network through AAM. The expansion into the pet care segment forms part of the company’s business diversification strategy beyond pharmaceutical and medical device distribution.